Oncology
Sysmex Inostics OncoBEAM™ Circulating Tumor DNA Technology Demonstrates Superior Response Prediction for Advanced Pancreatic Cancer over Standard-of-care Protein Biomarkers
Sysmex Inostics
PR-M11-18-NI-030Nov 08, 2018
Biopsy
Sysmex Inostics' OncoBEAM™ Liquid Biopsy Technology Demonstrates Utility for Clinical Management of Melanoma Patients Undergoing Treatment With Targeted Therapy and Immune Checkpoint Inhibitors
Sysmex Inostics
PR-M10-18-NI-061Oct 18, 2018